TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
VixiMed AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
188
|
168
|
232 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
20
|
-31
|
-1 |
| EBITDA |
20
|
-30
|
0 |
| Total assets |
110
|
97
|
153 |
| Current assets |
110
|
94
|
151 |
| Current liabilities |
37
|
39
|
59 |
| Equity capital |
73
|
58
|
93 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
66.4%
|
59.8%
|
60.8% |
| Turnover per employee |
188
|
168
|
232 |
| Profit as a percentage of turnover |
10.6%
|
-18.5%
|
-0.4% |
| Return on assets (ROA) |
18.2%
|
-32.0%
|
-0.7% |
| Current ratio |
297.3%
|
241.0%
|
255.9% |
| Return on equity (ROE) |
27.4%
|
-53.4%
|
-1.1% |
| Change turnover |
19
|
-46
|
-31 |
| Change turnover % |
12%
|
-21%
|
-12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.